Medication info
Lidoneur-DS Tablet (Risedronate Sodium, Cholecalciferol)

Lidoneur-DS Tablet (Risedronate Sodium, Cholecalciferol)

Prescription medicationTabletOral
Ingredient · strength
Risedronate Sodium 2.5 Hydrate›172.1mg / 1 tabletCholecalciferol›0.75mg / 1 tablet
Manufacturer / importer
Hanmi Pharmaceutical Co., Ltd.
Appearance
Blue oval film-coated tablet
Packaging
1 tablet/box [1 tablet/PTP x 1]
Approval status
Active

MFDS item code 201202525 · Approved 2012.04.03 · Insurance code 643506260

Summary

Main use
Treatment and prevention of osteoporosis in postmenopausal women
Who takes it
Adults · Children
Adult dose
1. Adults: Take 1 tablet of this drug orally once a month. 2. Older adults: No dose adjustment is necessary because the bioavailability and pharmacokinetics of this drug in older adults (60 years and older) are similar to those in younger people. 4. Patients with renal impairment: No dose adjustment is necessary for patients with creatinine clearance of 30ml/min or higher. This drug is contraindicated in patients with severe renal impairment and creatinine clearance below 30ml/min. Food interferes with absorption of this drug; for adequate absorption, take it at least 30 minutes before consuming the first food or beverage other than water of the day. To help this drug reach the stomach easily and reduce the possibility of esophageal irritation, take it in an upright position with a sufficient amount of plain water (170 ~ 230mL). Taking it with other beverages, including mineral water, may reduce absorption. Do not chew or suck this drug because of the possibility of oropharyngeal ulceration. Patients should not lie down for at least 30 minutes after taking it. Patients should take supplements if their dietary intake of calcium and vitamin D is inadequate. Patients at high risk of vitamin D deficiency (e.g., patients over 70 years of age, residents of nursing homes, and patients with chronic diseases) may require additional vitamin D supplements. Patients with gastrointestinal malabsorption syndrome may require higher doses of vitamin D supplements, and measurement of 25-hydroxyvitamin D concentrations should be considered. The recommended daily intake of vitamin D is 400IU to 800IU. One monthly dose of this drug provides a month's supply of vitamin D at 1000IU daily. If a patient forgets to take this drug on the scheduled day, follow these instructions: - If the next scheduled dose is at least 7 days away, take 1 tablet the next morning after remembering. Take the next dose on the originally scheduled day. Do not take more than 1 tablet of this drug within 7 days. - If the next scheduled dose is within 7 days, wait until the originally scheduled day and then take 1 tablet of this drug.
Child dose
3. Children: Safety and efficacy have not been established in children and adolescents who are still growing.

Ingredients

Manufacturer
Hanmi Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment and prevention of osteoporosis in postmenopausal women

  • Osteoporosis
View approved original text

This medication is used to treat and prevent osteoporosis that can occur in postmenopausal women. Osteoporosis is a condition characterized by weakened bone strength, leading to an increased risk of fractures, which is particularly common in postmenopausal women. Regular use of this medication can help increase bone density and reduce the risk of fractures. Therefore, it plays an important role in maintaining healthy bones in postmenopausal women.

How to take

Adult dose

1. Adults: Take 1 tablet of this drug orally once a month. 2. Older adults: No dose adjustment is necessary because the bioavailability and pharmacokinetics of this drug in older adults (60 years and older) are similar to those in younger people. 4. Patients with renal impairment: No dose adjustment is necessary for patients with creatinine clearance of 30ml/min or higher. This drug is contraindicated in patients with severe renal impairment and creatinine clearance below 30ml/min. Food interferes with absorption of this drug; for adequate absorption, take it at least 30 minutes before consuming the first food or beverage other than water of the day. To help this drug reach the stomach easily and reduce the possibility of esophageal irritation, take it in an upright position with a sufficient amount of plain water (170 ~ 230mL). Taking it with other beverages, including mineral water, may reduce absorption. Do not chew or suck this drug because of the possibility of oropharyngeal ulceration. Patients should not lie down for at least 30 minutes after taking it. Patients should take supplements if their dietary intake of calcium and vitamin D is inadequate. Patients at high risk of vitamin D deficiency (e.g., patients over 70 years of age, residents of nursing homes, and patients with chronic diseases) may require additional vitamin D supplements. Patients with gastrointestinal malabsorption syndrome may require higher doses of vitamin D supplements, and measurement of 25-hydroxyvitamin D concentrations should be considered. The recommended daily intake of vitamin D is 400IU to 800IU. One monthly dose of this drug provides a month's supply of vitamin D at 1000IU daily. If a patient forgets to take this drug on the scheduled day, follow these instructions: - If the next scheduled dose is at least 7 days away, take 1 tablet the next morning after remembering. Take the next dose on the originally scheduled day. Do not take more than 1 tablet of this drug within 7 days. - If the next scheduled dose is within 7 days, wait until the originally scheduled day and then take 1 tablet of this drug.

Child dose

3. Children: Safety and efficacy have not been established in children and adolescents who are still growing.

Precautions

This medication can irritate the mucous membranes of the stomach and esophagus, potentially leading to problems such as esophagitis or esophageal ulcers. It is important to take it with a sufficient amount of water and to avoid lying down for a period of time after taking it. If symptoms such as difficulty swallowing or heartburn occur during treatment, it should be discontinued immediately and a doctor should be consulted. Patients with esophageal disorders or upper gastrointestinal conditions such as gastritis or duodenitis should use this medication with caution. Patients with esophageal motility disorders or hypocalcemia, severe kidney disease, and pregnant or breastfeeding women should not take this medication. When taking this medication, ensure sufficient intake of calcium and vitamin D, and if deficient, consider taking supplements. Antacids or supplements containing divalent cations such as calcium, magnesium, or iron can interfere with the absorption of this medication and should not be taken together. In cases of dental surgery or oral infections, there may be a risk of osteonecrosis of the jaw, so it is essential to consult a doctor before treatment. This medication has not been established as safe and effective for children, so it is advisable not to use it in pediatric patients. In case of overdose, blood calcium levels may drop, so symptoms should be reported to healthcare professionals immediately for appropriate treatment. If any unusual symptoms occur during treatment, consult a doctor immediately and follow the prescribed dosing regimen carefully.

Side effects

  • Esophagitis
  • esophageal ulcer
  • esophageal erosion
  • esophageal obstruction
  • esophageal perforation
  • bleeding
  • dysphagia
  • odynophagia
  • retrosternal pain
  • heartburn
Show 130 more
  • gastric ulcer
  • duodenitis
  • glossitis
  • abnormal liver function test results
  • hypocalcemia
  • hypophosphatemia
  • infection
  • low back pain
  • pain
  • abdominal pain
  • neck pain
  • fatigue
  • chest pain
  • neoplasm
  • hernia
  • hypertension
  • cardiovascular disease
  • angina
  • nausea
  • diarrhea
  • bloating
  • gastritis
  • gastrointestinal disease
  • rectal disease
  • dental disease
  • purpura
  • anemia
  • arthralgia
  • joint abnormalities
  • myalgia
  • bone pain
  • bone abnormalities
  • leg cramps
  • bursitis
  • tendon abnormalities
  • depression
  • dizziness
  • insomnia
  • anxiety
  • neuralgia
  • vertigo
  • tension increase
  • sensory disturbances
  • pharyngitis
  • rhinitis
  • dyspnea
  • pneumonia
  • rash
  • itching
  • skin cancer
  • cataract
  • conjunctivitis
  • otitis media
  • urinary tract infection
  • cystitis
  • injury due to accident
  • epidemic cold syndrome
  • headache
  • overdose
  • allergic reaction
  • syncope
  • vasodilation
  • constipation
  • dyspepsia
  • nausea
  • gastroenteritis
  • colitis
  • vomiting
  • thirst
  • peripheral edema
  • traumatic fracture
  • myopathy
  • arthritis
  • bronchitis
  • sinusitis
  • increased cough
  • tumor
  • fever
  • falls
  • upper abdominal pain
  • abdominal distension
  • hiatal hernia
  • dry mouth
  • influenza
  • nasopharyngitis
  • upper respiratory tract inflammation
  • low back pain
  • osteoarthritis
  • limb pain
  • muscular rigidity
  • neck pain
  • weakness
  • hypercholesterolemia
  • uveitis
  • iritis
  • jawbone necrosis
  • Stevens-Johnson syndrome
  • toxic epidermal necrolysis
  • angioedema
  • blisters
  • skin reactions
  • jawbone necrosis
  • jaundice
  • external auditory canal osteonecrosis
  • dyspepsia
  • loss of appetite
  • chest discomfort
  • epigastric pain
  • chest unease
  • palpitations
  • increased sweating
  • facial flushing
  • burning sensation
  • kidney stones
  • belching
  • hematuria
  • fever
  • chills
  • gastric dysfunction
  • hypocalcemia
  • hypercalcemia
  • hypercalciuria
  • loss of appetite
  • nausea
  • vomiting
  • polyuria
  • ptyalism
  • weakness
  • drowsiness
  • abnormal liver function test results

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent air and moisture from entering, and it is recommended to store it at room temperature between 1°C and 30°C. Storing it this way can help maintain the medication's effectiveness for a longer time.

Appearance and packaging

Appearance

Blue oval film-coated tablet

Package unit

1 tablet/box [1 tablet/PTP x 1]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.